InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Dalal Anupam, Director. Officer active across 2 companies, notably Aerpio Pharmaceuticals, Inc.. Aggregated, 8 reports have been published. Split: 4 buys · 0 sell. Total volume traded: €68m. Activity tracked since 30 June 2021. The latest transaction was disclosed on 4 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
1,561,000 shares@ US$2.404.7% of flowCommon StockSEC:0001415889-25-007096:0
320,000 shares@ US$12.505.5% of flowCommon StockSEC:0001209191-22-051390:0
1,529,402 shares@ US$13.07725.0% of flowCommon StockSEC:0000899243-21-034635:0
Ideal exit: 23 May 2022 (T+270)
1,529,402 shares@ US$13.07722.4% of flowCommon StockSEC:0000899243-21-034635
Ideal exit: 23 May 2022 (T+270)
1,529,402 shares@ US$13.07722.4% of flowCommon StockSEC:0000899243-21-034546
Ideal exit: 23 May 2022 (T+270)
1,529,402 shares@ US$13.07725.0% of flowCommon StockSEC:0000899243-21-034546:0
Ideal exit: 23 May 2022 (T+270)
7,400 shares@ US$1.5250.0% of flowCommon StockSEC:0000899243-21-027291:0
7,400 shares@ US$1.5250.0% of flowCommon StockSEC:0000899243-21-027291
8 of 8 declarations
About Dalal Anupam
Anupam Dalal is a Board Member at Aerpio Pharmaceuticals, Inc. and Aadi Bioscience, Inc. He contributes to the governance of these companies by participating in strategic decision-making and overseeing operations. His expertise is valuable for the development of these organizations.
